Cargando…

Ticagrelor induced systemic inflammatory response syndrome

BACKGROUND: Ticagrelor is a reversible and direct-acting oral antagonist of the adenosine diphosphate receptor P2Y12. Possible adenosine-mediated effects of ticagrelor on inflammation are complex and incompletely understood. To our knowledge, ticagrelor-induced systemic inflammatory response syndrom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krisai, Philipp, Haschke, Manuel, Buser, Peter T., Mueller, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217217/ https://www.ncbi.nlm.nih.gov/pubmed/28056791 http://dx.doi.org/10.1186/s12872-016-0443-8

Ejemplares similares

Ticagrelor-Induced Prolongation of the QTc Interval
por: Ray, Avik, et al.
Publicado: (2019)

A Case Report of Ticagrelor-Induced Thrombocytopenia
por: Alsalman, Mortadah
Publicado: (2023)

Ticagrelor-Induced Angioedema: A Rare and Unexpected Phenomenon
por: Seecheran, Rajeev, et al.
Publicado: (2017)

Cyclical sinus bradycardia and atrioventricular block induced by ticagrelor
por: Waldmann, Victor, et al.
Publicado: (2018)

Ticagrelor: Angioedema: case report
Publicado: (2021)

Hypersensitivity to ticagrelor and low response to clopidogrel: a case report
por: Dai, Jing, et al.
Publicado: (2017)

Ticagrelor-Induced Torsades de Pointes following Myocardial Infarction
por: Bu, Seong Hyeon, et al.
Publicado: (2022)

Ticagrelor-associated thrombotic thrombocytopenic purpura
por: Doğan, Ali, et al.
Publicado: (2017)

Ticagrelor as an Alternative for Clopidogrel-Associated Acute Arthritis
por: Bedy, Starr-Mar'ee C., et al.
Publicado: (2018)

Effect of altitude on ticagrelor-induced dyspnea in patients with acute coronary syndrome
por: Kocabay, Gonenc, et al.
Publicado: (2023)

Ticagrelor: A safe option as part of triple therapy?
por: Farooq, Mohammad Umar
Publicado: (2020)

Ticagrelor Associated Heart Block: The Need for Close and Continued Monitoring
por: Sharma, Munish, et al.
Publicado: (2017)

Ticagrelor therapy and atrioventricular block: Do we need to worry?
por: De Maria, Elia, et al.
Publicado: (2017)

Potential Additive Effects of Ticagrelor, Ivabradine, and Carvedilol on Sinus Node
por: Di Serafino, Luigi, et al.
Publicado: (2014)

Ticagrelor-Induced Syncope/Bradyarrhythmia
por: Kotaru, VeeraPavan, et al.
Publicado: (2021)

Ticagrelor-induced acute kidney injury can increase serum concentration of statin and lead to concurrence of rhabdomyolysis
por: Park, In Seong, et al.
Publicado: (2018)

Ticagrelor-Associated Conduction Disorder: A Case Report and Review of the Literature
por: Yurtdas, Mustafa, et al.
Publicado: (2017)

Ticagrelor-associated ventricular pauses: a case report and literature review
por: Low, Ashlea, et al.
Publicado: (2018)

A rare but serious complication of ticagrelor therapy: a case report
por: Arioti, Manfredi, et al.
Publicado: (2020)

Prolonged ventricular pause associated with ticagrelor use: A case report
por: Rahhal, Alaa, et al.
Publicado: (2021)

Aspirin/ticagrelor: Haemoperitoneum and hepatic subcapsular haematoma: 2 case reports
Publicado: (2021)

Aspirin/clopidogrel/ticagrelor: Diffuse ooze and bleeding: 2 case reports
Publicado: (2021)

Isolated double-orifice mitral valve: a case report
por: Krisai, Philipp, et al.
Publicado: (2015)

Systemic Inflammatory Response Syndrome Secondary to Nitrofurantoin
por: McGarry, Molly R., et al.
Publicado: (2021)

Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor
por: Banakh, Iouri, et al.
Publicado: (2017)

Diffuse alveolar hemorrhage associated with ticagrelor therapy after percutaneous coronary intervention
por: Yılmaz, Samet, et al.
Publicado: (2018)

Ticagrelor-Related Severe Dyspnoea: Mechanisms, Characteristic Features, Differential Diagnosis and Treatment
por: Krakowiak, Alicja, et al.
Publicado: (2020)

Metabolism of ticagrelor in patients with acute coronary syndromes
por: Adamski, Piotr, et al.
Publicado: (2018)

Real‐World Evidence on Disparities on the Initiation of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome
por: Yildirim, Mustafa, et al.
Publicado: (2023)

Spontaneous subdural hematoma and antiplatelet therapy: Does efficacy of Ticagrelor come with added risk?
por: Suryanarayana Sharma, Pattanagere Manjunatha, et al.
Publicado: (2015)

Pathophysiological and Molecular Basis of the Side Effects of Ticagrelor: Lessons from a Case Report
por: Cesarini, Daniel, et al.
Publicado: (2023)

Granulocytic sarcoma: An uncommon cause of systemic inflammatory response syndrome
por: Rajaretnam, Niroshini, et al.
Publicado: (2019)

Walking the Line with Ticagrelor: Meta-Analysis Comparing the Safety and Efficacy of Ticagrelor Monotherapy after a Short Course of Ticagrelor-Based Dual Antiplatelet Therapy versus Standard Therapy in Complex Percutaneous Coronary Intervention
por: Condello, Francesco, et al.
Publicado: (2021)

Acute Kidney Injury Induced by Systemic Inflammatory Response Syndrome is an Avid and Persistent Sodium-Retaining State
por: Vitorio, Daniel, et al.
Publicado: (2014)

Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor
por: Birkeland, Kade, et al.
Publicado: (2010)

Critical appraisal of ticagrelor in the management of acute coronary syndrome
por: Nawarskas, James J, et al.
Publicado: (2011)

Successful Caesarean Section on Ticagrelor Treatment One Day after Primary Percutaneous Coronary Intervention
por: Antonijevic, Nebojsa, et al.
Publicado: (2023)

A Case of Ticagrelor-Induced Sinus Pause
por: Pavlatos, Nicholas T, et al.
Publicado: (2023)

Unraveling the pharmacokinetic interaction of ticagrelor and MEDI2452 (Ticagrelor antidote) by mathematical modeling
por: Almquist, J, et al.
Publicado: (2016)

Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes
por: Ndrepepa, Gjin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_67brca2shi054p2b1o6e58kda4